Tailor Bio

Developing a pan-cancer precision medicine platform by decoding Chromosomal Instability.

[Tailor Bio @TailorBio]

Tailor Bio is delighted to be collaborating with @VolastraTx on their KIF18A inhibitor programs! Our platform brings unique insight into cancers with Chromosomal Instability, and has been developed from groundbreaking research from @CR_UK and @CNIOStopCancer

[Volastra Therapeutics @VolastraTx]

We are proud to announce strategic partnerships that add robustness to our differentiated #biomarker-driven strategy, allowing us to broaden the impact of our #KIF18A inhibitor medicines for #cancer patients. Learn more here: https://t.co/Te8pCRp0QE.
#chromosomal_instability

[Florian Markowetz @markowetzlab]

All models are wrong and yours are useless!

In case you missed my talk yesterday on how to make clinical prediction tools useful for patients, you can read all about it here.

Enjoy!

https://t.co/WAG8yz1y65

[Tailor Bio @TailorBio]

Tailor Bio has been featured in Sifted’s ranking of the 20 most promising early-stage cancer tech startups to watch across Europe. We're thrilled to be selected! Thank you to @Siftedeu and @DebiopharmFund for the recognition. https://t.co/bpX5TCEaED

[Tailor Bio @TailorBio]

We're #hiring at Tailor Bio! We’re looking for an experienced Research Scientist to support our drug screening and genomics projects. If you are passionate about cutting edge technologies that can make an impact on cancer treatment, then click below! https://t.co/sw8Xk7LqSR

[Tailor Bio @TailorBio]

Excited to share our latest work done in collaboration with the Macintyre, Markowetz and Brenton Labs on using CIN signatures to predict chemotherapy response!
.
https://t.co/LPPWPkXwhO
.
@CNIOStopCancer @CRUK_CI @TailorBio #precisionmedicine

[Geoff Macintyre @gjmacintyre]

Thrilled to share our study predicting response to multiple chemotherapies using a single genomic test! https://t.co/NjF28Dr11d cant wait to move this to clinical trials with @TailorBio to transform chemo into a precision medicine! Collab b/w @TailorBio @CNIOStopCancer @CRUK_CI

[Tailor Bio @TailorBio]

Congratulations to our Advisor, Professor Sir Steve Jackson on receiving his knighthood in the #KingsBirthdayHonours! We are very fortunate to benefit from his contributions and advice at Tailor Bio and wish him all the best.
@SPJacksonGroup

[CRUK Cambridge Institute @CRUK_CI]

Hearty congratulations to Prof Sir Steve Jackson, Senior Group Leader @CRUK_CI, who has received a knighthood in the King's first #BirthdayHonours List for his services to innovation and research 🎉

Read more about his remarkable achievement here⬇️
https://t.co/bUtHs3vPkb

[Barbara Hernando @BHFHeptathlon]

📣 JOB ALERT!

We are looking for a senior scientist to lead our experimental work. Great opportunity to join our fantastic team in Spain!

Please RT!

[AlbionVC @AlbionVC]

#Drugdiscovery startups bagged a record of $5.5 B globally in 2021 @dealroomco.
Despite the process being costly the return on impact remains high.
Here's a list of 14 startups that are set to take off according to VCs. Thanks,
@r1ddhi, @BusinessInsider
https://t.co/w206R9xt0P

[Geoff Macintyre @gjmacintyre]

Had a fantastic time at the #BISTConference. Great quality talks and huge breadth of science. Thanks for the invitation!

[Tailor Bio @TailorBio]

Tailor Bio is #hiring! We’re currently looking for up to two (2) individuals with #bioinformatics experience to join our mission-driven team. If you're interested in joining an exciting mission-driven #startup, please reach out! https://t.co/vdcLcWBtG5

[GenomeWeb @GenomeWeb]

Tailor Bio Receives £650K UK Biomedical Grant to Develop Predictive Diagnostic for Ovarian Cancer. The startup will work with Illumina and the University of Cambridge to develop a test that identifies which ovarian cancer patients won't respond to... https://t.co/KvDoD3rVwt

[Florian Markowetz @markowetzlab]

Go @TailorBio !

[Geoff Macintyre @gjmacintyre]

I love seeing the CEO's smiling face. He definitely has something to smile about @TailorBio https://t.co/GiL9DuJdgp

[Tailor Bio @TailorBio]

The collaboration between @TailorBio, @illumina and @Cambridge_Uni (Brenton laboratory) will assess the compatibility of our platform with the Illumina TruSight Oncology Comprehensive, which has now received CE-IVD marking in Europe. #precisionmedicine #oncology #biomarkers

[Tailor Bio @TailorBio]

We're delighted to have been awarded a grant by the Innovate UK Biomedical Catalyst competition to support the development of our platform and our ability to predict doxorubicin response in ovarian cancer. https://t.co/G1r7b0fstY

[Geoff Macintyre @gjmacintyre]

Macintyre Lab and @TailorBio on tour #EACR2022

[Florian Markowetz @markowetzlab]

When you have a paper in a flashy journal they ask you to send in some artsy pieces to maybe put on the cover.

Next week you will see what they picked, but here are some that surprisingly did not make the cut.

A🧵 on #17DeadlyCINs

First up, the PANDEMONIUM OF CIN ... 1/

[Volastra Therapeutics @VolastraTx]

Congratulations to @TailorBio on their recent @Nature cover feature! #Chromosomal_Instability is quickly becoming one of cancer’s most talked about vulnerabilities. We are excited to have others digging into this space and about the discoveries yet to emerge from this work. 👏👏

[Tailor Bio @TailorBio]

Finally - the actual publication available here! https://t.co/k0sNWRQ3Us

[Tailor Bio @TailorBio]

Congratulations to our co-founders for their work being selected to appear on the cover of @Nature this week. Fantastic recognition of what is a fundamental step change in our understanding of chromosomal instability. #17DeadlyCINs

[Tailor Bio @TailorBio]

For an inside look at the #17DeadlyCINs, check out @gjmacintyre's tweetorial here: https://t.co/PLYiEwkoTY

[Geoff Macintyre @gjmacintyre]

Chromosomal INstability causes chaotic cancer genomes. Making sense of this chaos was hard. Come sit around the fire and listen to our tale of The #17DeadlyCINs a gripping epic of mechanisms of CIN, therapy response prediction and drug target discovery
https://t.co/mXAeYNNZVg 1/